BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34938)

  • 1. [Beta-receptor blockers in ischemic heart disease: the pathophysiological and clinical aspects].
    Urbaszek W; Modersohn D
    Z Arztl Fortbild (Jena); 1979 Feb; 73(3):101-6. PubMed ID: 34938
    [No Abstract]   [Full Text] [Related]  

  • 2. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.
    Frishman WH
    Circulation; 1983 Jun; 67(6 Pt 2):I11-8. PubMed ID: 6133640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Bragina GI
    Ter Arkh; 1979; 51(8):13-7. PubMed ID: 41333
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intrinsic sympathomimetic activity with beta-receptor blockers. Significance for differential therapy (author's transl)].
    Noack E
    MMW Munch Med Wochenschr; 1982 Apr; 124(15):377-80. PubMed ID: 6123078
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of adrenergic beta blockers on hemodynamics, diastolic relaxation and distensibility of left-ventricular myocardium in patients with ischemic heart disease].
    Moroz VA; Gladchenko AR; Latoguz IK; Khimenko PL
    Klin Med (Mosk); 1991 Jan; 69(1):47-8. PubMed ID: 1673730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta receptor blockers in coronary insufficiency and acute infarct. Pathophysiological bases].
    Bleifeld W; Kupper W
    Dtsch Med Wochenschr; 1988 Apr; 113(14):565-70. PubMed ID: 2895701
    [No Abstract]   [Full Text] [Related]  

  • 7. [The therapy of chronic heart failure with beta-receptor blockers?].
    Schwinger RH; Böhm M; Erdmann E
    Dtsch Med Wochenschr; 1990 May; 115(21):825-31. PubMed ID: 1971212
    [No Abstract]   [Full Text] [Related]  

  • 8. Verapamil in treatment of chronic stable angina.
    Frishman WH; Charlap S
    Arch Intern Med; 1983 Jul; 143(7):1407-15. PubMed ID: 6135403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
    Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of coronary insufficiency with beta-receptor antagonists (author's transl)].
    Hitzenberger G
    Arzneimittelforschung; 1977; 27(3a):700-2. PubMed ID: 17414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD; Hillis LD
    Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Andrushchenko EV; Chmir VP; Krasovskaia EA; Malanchuk TA; Polishchuk II; Iashchenko OB
    Vrach Delo; 1990 Nov; (11):35-8. PubMed ID: 1983050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of ischemic heart disease with beta-receptor blockers and isosorbide dinitrate (author's transl)].
    Wermuth G
    MMW Munch Med Wochenschr; 1975 Oct; 117(40):1613-4. PubMed ID: 241932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of strophanthin in adrenergic blockade on the blood supply and work of the heart in acute coronary artery occlusion].
    Sapozhkov AV; Verger DIa; Vakhrameev NIa
    Farmakol Toksikol; 1983; 46(1):42-5. PubMed ID: 6297963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correction of extracardiac effects on the heart as a method of treating ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Litvitskiĭ PF; Bragina GI
    Farmakol Toksikol; 1982; 45(3):53-9. PubMed ID: 6284550
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic aspects of the treatment of ischemic heart disease.
    Wellens D
    Angiology; 1977 Dec; 28(12):839-43. PubMed ID: 23714
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta blockers in ischemic cardiopathy].
    Cía Gómez P
    Rev Esp Cardiol; 1984; 37 Suppl 1():2-8. PubMed ID: 6150526
    [No Abstract]   [Full Text] [Related]  

  • 19. [Capillary hyperlactacidemia, criterion of exertion intolerance in patients treated with beta-blockaders].
    Haissly JC; Junod A; Curati W; Robert M; Rossel CF
    Schweiz Med Wochenschr; 1974 Nov; 104(44):1592-3. PubMed ID: 4153818
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.